Disciplined Investments’s iShares Biotechnology ETF IBB Stock Holding History

Disciplined Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-218	Closed	-$27.7K	–	763
2023 Q2	$27.7K	Hold	218	–	–	0.01%	254
2023 Q1	$28.2K	Hold	218	–	–	0.01%	274
2022 Q4	$28.7K	Sell	218 -36	-14%	-$4.65K	0.01%	251
2022 Q3	$30K	Hold	254	–	–	0.01%	269
2022 Q2	$30K	Hold	254	–	–	0.01%	271
2022 Q1	$33K	Hold	254	–	–	0.01%	275
2021 Q4	$39K	Hold	254	–	–	0.02%	234
2021 Q3	$41K	Hold	254	–	–	0.02%	216
2021 Q2	$42K	Buy	254 +132	+108%	+$20.3K	0.02%	208
2021 Q1	$18K	Buy	122 +39	+47%	+$6.2K	0.01%	239
2020 Q4	$13K	Hold	83	–	–	0.01%	218
2020 Q3	$11K	Sell	83 -44	-35%	-$5.97K	0.01%	252
2020 Q2	$17K	Sell	127 -57	-31%	-$7.27K	0.01%	242
2020 Q1	$20K	Hold	184	–	–	0.02%	214
2019 Q4	$22K	Buy	+184	New	+$20.5K	0.02%	236

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Disciplined Investments's IBB Position: Q3 2023 in Review

Disciplined Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 218 shares — an estimated $27.7K sold.

Disciplined Investments first reported a position in IBB in Q4 2019 and held it in 15 quarters. The position peaked at $42K in Q2 2021. 832 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Disciplined Investments reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
Disciplined Investments sold 218 iShares Biotechnology ETF shares in Q3 2023, an estimated $27.7K.
Disciplined Investments first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 15 quarters.
Disciplined Investments's iShares Biotechnology ETF position peaked at $42K in Q2 2021.
832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.